IPAD-DB ID | S01212 |
Name | 2-methyl-5, 6, 7, 8-tetrahydro-4H-[1]benzothieno[2, 3- d][1, 3]oxazin-4-one (3) |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 1 H 1 1 N O 2 S |
Molecular Weight | 221.28 g/mol |
IUPAC Name | 2-methyl-5, 6, 7, 8-tetrahydro-[1]benzothiolo[2, 3-d][1, 3]oxazin-4-one |
InChI | InChI=1S/C11H11NO2S/c1-6-12-10-9(11(13)14-6)7-4-2-3-5-8(7)15-10/h2-5H2, 1H3 |
InChIKey | MSLWJDFZJOUINW-UHFFFAOYSA-N |
Canonical SMILES | CC1=NC2=C(C3=C(S2)CCCC3)C(=O)O1 |
PubChem CID | 384428 |
DrugBank Accession Number | - |
CAS Registry Number | 13130-47-7 |
Molecular Weight(Computed by SwissADME) | 221.28 |
Hac(Computed by SwissADME) | 15 |
Volume(Computed by ADMETlab 2.0) | 209.683 |
Density(Computed by ADMETlab 2.0) | 1.054 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 13 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 16 |
Flexibility(Computed by ADMETlab 2.0) | 0 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -4.631 |
LogD(Computed by ADMETlab 2.0) | 2.879 |
logP(Computed by ADMETlab 2.0) | 2.826 |
TPSA(Computed by SwissADME) | 71.34 |
Hbond Acceptor(Computed by SwissADME) | 3 |
Hbond Donor(Computed by SwissADME) | 0 |
Rotatable Bonds(Computed by SwissADME) | 0 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -5.87 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |